Page last updated: 2024-08-17

aspartic acid and telaprevir

aspartic acid has been researched along with telaprevir in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brennan, DL; Cottrell, KM; Fulghum, JR; Gates, CA; Hsiao, HM; Kwong, AD; Lin, C; Lin, K; Luong, YP; Ma, S; Maxwell, JP; Perni, RB; Rao, BG; Wei, YY	1
Brennan, DL; Frantz, JD; Fulghum, JR; Gates, CA; Kwong, AD; Lin, C; Lin, K; Luong, YP; Ma, S; Perni, RB; Rao, BG; Wei, YY	1

Other Studies

2 other study(ies) available for aspartic acid and telaprevir

Article	Year
In vitro resistance studies of hepatitis C virus serine protease inhibitors, VX-950 and BILN 2061: structural analysis indicates different resistance mechanisms. The Journal of biological chemistry, 2004, Apr-23, Volume: 279, Issue:17 Topics: Amino Acids; Aspartic Acid; Binding Sites; Carbamates; Dose-Response Relationship, Drug; Drug Resistance; Enzyme Inhibitors; Genes, Dominant; Hepacivirus; Inhibitory Concentration 50; Kinetics; Macrocyclic Compounds; Models, Chemical; Models, Molecular; Mutation; Oligopeptides; Plasmids; Protein Structure, Tertiary; Quinolines; Serine Proteinase Inhibitors; Thiazoles; Time Factors; Viral Nonstructural Proteins	2004
In vitro studies of cross-resistance mutations against two hepatitis C virus serine protease inhibitors, VX-950 and BILN 2061. The Journal of biological chemistry, 2005, Nov-04, Volume: 280, Issue:44 Topics: Amino Acid Substitution; Amino Acids; Aspartic Acid; Binding Sites; Carbamates; Drug Resistance, Viral; Genes, Dominant; Hepacivirus; Humans; In Vitro Techniques; Inhibitory Concentration 50; Kinetics; Macrocyclic Compounds; Models, Chemical; Models, Molecular; Mutation; Oligopeptides; Quinolines; Replicon; RNA, Viral; Serine Proteinase Inhibitors; Thiazoles; Viral Nonstructural Proteins	2005

Article

Year

In vitro resistance studies of hepatitis C virus serine protease inhibitors, VX-950 and BILN 2061: structural analysis indicates different resistance mechanisms.

The Journal of biological chemistry, 2004, Apr-23, Volume: 279, Issue:17

Topics: Amino Acids; Aspartic Acid; Binding Sites; Carbamates; Dose-Response Relationship, Drug; Drug Resistance; Enzyme Inhibitors; Genes, Dominant; Hepacivirus; Inhibitory Concentration 50; Kinetics; Macrocyclic Compounds; Models, Chemical; Models, Molecular; Mutation; Oligopeptides; Plasmids; Protein Structure, Tertiary; Quinolines; Serine Proteinase Inhibitors; Thiazoles; Time Factors; Viral Nonstructural Proteins

2004

In vitro studies of cross-resistance mutations against two hepatitis C virus serine protease inhibitors, VX-950 and BILN 2061.

The Journal of biological chemistry, 2005, Nov-04, Volume: 280, Issue:44

Topics: Amino Acid Substitution; Amino Acids; Aspartic Acid; Binding Sites; Carbamates; Drug Resistance, Viral; Genes, Dominant; Hepacivirus; Humans; In Vitro Techniques; Inhibitory Concentration 50; Kinetics; Macrocyclic Compounds; Models, Chemical; Models, Molecular; Mutation; Oligopeptides; Quinolines; Replicon; RNA, Viral; Serine Proteinase Inhibitors; Thiazoles; Viral Nonstructural Proteins

2005